iCarbonX

iCarbonX was founded in October 2015 by genomicist Jun Wang, the former CEO of BGI. Its first aim was AI-driven personal health management, built on genomic, proteomic, metabolomic and microbiome data. Since 2019 it has refocused on an open, one-stop multi-omics lab and data-analysis platform for biopharma and biotech partners. It is privately held and was valued at about $1B in 2018. Funding totals are reported as roughly $200M (Tencent, China Bridge Capital and others) up to $366M including a 2021 Series D. Headcount is small, at about 60–66 in 2026.